Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis
Hepatocellular carcinoma (HCC), the fourth leading cause of cancer mortality worldwide,
develops almost exclusively in patients with chronic liver disease and advanced fibrosis …
develops almost exclusively in patients with chronic liver disease and advanced fibrosis …
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis.
A Filliol, Y Saito, A Nair, DH Dapito, LX Yu… - 2022 - mediatum.ub.tum.de
Hepatocellular carcinoma (HCC), the fourth leading cause of cancer mortality worldwide,
develops almost exclusively in patients with chronic liver disease and advanced fibrosis1, 2 …
develops almost exclusively in patients with chronic liver disease and advanced fibrosis1, 2 …
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis
A Filliol, Y Saito, A Nair, D Dapito, LX Yu… - Nature, 2022 - hal.insa-toulouse.fr
Hepatocellular carcinoma (HCC), the fourth leading cause of cancer mortality worldwide,
develops almost exclusively in patients with chronic liver disease and advanced fibrosis1, 2 …
develops almost exclusively in patients with chronic liver disease and advanced fibrosis1, 2 …
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis.
A Filliol, Y Saito, A Nair, DH Dapito, LX Yu… - Nature, 2022 - europepmc.org
Hepatocellular carcinoma (HCC), the fourth leading cause of cancer mortality, develops
almost exclusively in patients with chronic liver disease (CLD) and advanced fibrosis 1, 2 …
almost exclusively in patients with chronic liver disease (CLD) and advanced fibrosis 1, 2 …
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis
A Filliol, Y Saito, A Nair, DH Dapito… - …, 2022 - utsouthwestern.elsevierpure.com
Hepatocellular carcinoma (HCC), the fourth leading cause of cancer mortality worldwide,
develops almost exclusively in patients with chronic liver disease and advanced fibrosis 1, 2 …
develops almost exclusively in patients with chronic liver disease and advanced fibrosis 1, 2 …
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis
A Filliol, Y Saito, A Nair, DH Dapito, LX Yu… - Nature, 2022 - ideas.repec.org
Hepatocellular carcinoma (HCC), the fourth leading cause of cancer mortality worldwide,
develops almost exclusively in patients with chronic liver disease and advanced fibrosis1, 2 …
develops almost exclusively in patients with chronic liver disease and advanced fibrosis1, 2 …
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis
A Filliol, Y Saito, A Nair, D Dapito, LX Yu… - Nature, 2022 - hal.science
Hepatocellular carcinoma (HCC), the fourth leading cause of cancer mortality, develops
almost exclusively in patients with chronic liver disease (CLD) and advanced fibrosis1, 2 …
almost exclusively in patients with chronic liver disease (CLD) and advanced fibrosis1, 2 …
[HTML][HTML] Opposing Roles of Hepatic Stellate Cell Subpopulations in Hepatocarcinogenesis
A Filliol, Y Saito, A Nair, DH Dapito, LX Yu… - Nature, 2022 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC), the fourth leading cause of cancer mortality, develops
almost exclusively in patients with chronic liver disease (CLD) and advanced fibrosis 1, 2 …
almost exclusively in patients with chronic liver disease (CLD) and advanced fibrosis 1, 2 …
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis
A Filliol, Y Saito, A Nair, DH Dapito, LX Yu… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC), the fourth leading cause of cancer mortality worldwide,
develops almost exclusively in patients with chronic liver disease and advanced fibrosis 1, 2 …
develops almost exclusively in patients with chronic liver disease and advanced fibrosis 1, 2 …
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis
A Filliol, Y Saito, A Nair, DH Dapito, LX Yu… - Nature, 2022 - econpapers.repec.org
Hepatocellular carcinoma (HCC), the fourth leading cause of cancer mortality worldwide,
develops almost exclusively in patients with chronic liver disease and advanced fibrosis1, 2 …
develops almost exclusively in patients with chronic liver disease and advanced fibrosis1, 2 …